Asia Pacific Polymerase Chain Reaction Technologies Market By Technology (Real-Time, Digital, Traditional), Application (Forensics, Research, Clinical), Product (Instruments, Reagents & Consumables, Software, Services), End User (Biotech & Pharma Companies, Diagnostic Centers & Hospitals, Academic & Research Institutions)
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Polymerase Chain Reaction Technologies Market
Market Report Description
The Asia Pacific Polymerase Chain Reaction Technologies Market would witness market growth of 7.3% CAGR during the forecast period (2018 – 2024). Polymerase chain reaction technology devices are medical devices that are primarily used to generate thousands to millions of copies of a piece of deoxyribonucleic acid (DNA). These devices are majorly used in different life science fields such as genetics, molecular biology research, biotechnology, drug discovery, and clinical diagnostics. Growing geriatric population, growing prevalence of infectious diseases, rapidly growing diagnostic centers and hospitals, technological advancements, and growing awareness and acceptance of personalized medicine are the factors that drive the polymerase chain reaction technologies market.
Nevertheless, growing non-validated home-brew tests and reimbursement issues are the factors that limit the growth of the market. Also, accuracy and timely results for RT-PCR would further add to the challenges to the polymerase chain reaction technologies growth. Less tedious processes open avenues for the PCR market. Additionally, increasing funding towards research and development activities and large untapped markets in developing regions would further add to the market opportunities during the forecast period.
Based on Technology, the market is segmented into Real Time PCR, Digital PCR and Traditional PCR. Based on Application, the market is segmented into Forensics, Research and Clinical. Based on Product, the market is segmented into Instruments, Reagents & consumables, Software and Services. Based on End user, the market is segmented into Biotech & Pharma Company, Diagnostics Centers & Hospitals and Academic & Research Institutions. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, BioMérieux, Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd., Fluidigm Corporation, LGC Limited, Qiagen NV, SYGNIS Pharma AG, Takara Bio, Inc., Thermo Fisher Scientific.
Scope of the Study
Market Segmentation:
By Technology
- Real-time PCR
- Digital PCR
- Traditional PCR
By Application
- Forensics
- Research
- Clinical
By Product
- Instruments
- Reagents & Consumables
- Software
- Services
By End User
- Biotech & Pharma Company
- Diagnostics Centers & Hospitals
- Academic & Research Institutions
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Companies Profiled
- Agilent Technologies
- BioMérieux
- Bio-Rad Laboratories, Inc.
- Hoffmann-La Roche Ltd
- Fluidigm Corporation
- LGC Limited
- Qiagen NV
- SYGNIS Pharma AG
- Takara Bio, Inc.
- Thermo Fisher Scientific
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Related Reports:
Global Polymerase Chain Reaction Technologies Market (2018-2024)
North America Polymerase Chain Reaction Technologies Market (2018-2024)
Europe Polymerase Chain Reaction Technologies Market (2018-2024)
LAMEA Polymerase Chain Reaction Technologies Market (2018-2024)